Researchers identified mutational signatures characteristic of chemotherapy exposure PHILADELPHIA – Researchers identified a higher rate of clonal hematopoiesis (CH)...
American Association for Cancer Research (AACR) President Lisa M. Coussens, PhD, FAACR, issued the following statement on President Biden’s...
PHILADELPHIA — The American Association for Cancer Research (AACR) and the African Organisation for Research and Training in Cancer...
Responses to the off-the-shelf therapy were observed in 95 percent of patients PHILADELPHIA – Posoleucel, an investigational allogeneic off-the-shelf...
PHILADELPHIA — The American Association for Cancer Research (AACR) will award the 19th AACR-Irving Weinstein Foundation Distinguished Lectureship to...
SAN ANTONIO – Patients with multiple tumors in the same breast who underwent a lumpectomy followed by radiation therapy...
SAN ANTONIO – Patients with invasive breast cancer who had low scores on an investigational gene molecular signature had...
SAN ANTONIO – The next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compared with fulvestrant (Faslodex), in...
SAN ANTONIO – In patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of the investigational...
SAN ANTONIO – The use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine...